Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Crenezumab Biosimilar – Anti-APP Abeta42 and Abeta40 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG4, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Crenezumab Biosimilar - Anti-APP Abeta42 and Abeta40 mAb - Research Grade |
|---|---|
| Source | CAS 1095207-05-8 |
| Species | Humanized |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Crenezumab,MABT5102A,RG7412,APP Abeta42 and Abeta40,anti-APP Abeta42 and Abeta40 |
| Reference | PX-TA1269 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG4-kappa |
| Clonality | Monoclonal Antibody |
Description of Crenezumab Biosimilar - Anti-APP Abeta42 and Abeta40 mAb - Research Grade
General information on Anti-APP Abeta42 and Abeta40[Homo sapiens] (Crenezumab) Monoclonal Antibody
Crenezumab has been investigated for the treatment of Alzheimer’s Disease.
Related products
Antigen
Human APP (18-705) Recombinant Protein
PX-P1059 210€
Isotype Control
Human IgG4 Isotype Control antibody
PTX17887 180€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.